目的 了解江门市人民医院女性乳腺异常和恶性结果。方法 收集2015—2020年江门市人民医院40 068例女性乳腺彩超检查资料,其中体检者13 638例,非体检者26 430例,分析不同年龄不同年份女性乳腺异常结果和恶性结果检出率。结果 非体检人群中异常结果5 631例,占21.31%;恶性结果(BI-RADS分级5级)220例,占0.83%;不同年龄女性乳腺异常结果检出率差异无统计学意义(χ2趋势=2.837,P=0.092)。随年龄增长,女性乳腺恶性结果检出率呈上升趋势(χ2趋势=319.091,P<0.001);不同年份女性乳腺异常结果和恶性结果检出率均呈上升趋势(χ2趋势=106.183,P<0.001;χ2趋势=12.181,P<0.001)。体检人群中异常结果1 002例,恶性结果5例,体检人群异常结果和恶性结果检出率均显著低于非体检人群检出率(χ2=1 268.803,P<0.001,χ2=102.009,P<0.001)。结论 女性乳腺疾病筛查状况不容乐观,有待于进一步加强。
Abstract
Objective To understand the abnormal and malignant results of female breast in the People’s Hospital of Jiangmen. Methods The color Doppler ultrasound examination data of 4 068 women in the People’s Hospital of Jiangmen from 2015 to 2020 were collected,including 13 638 physical examiners and 26 430 non physical examiners.The detection rates of abnormal and malignant breast results of women of different ages and years were analyzed. Results Among the non-physical examination population,there were 5 631 abnormal results,accounting for 21.31%,and 220 malignant results (BI-RADS grade 5),accounting for 0.83%.There was no significant relationship between abnormal results and age(χ2trend=2.837,P=0.092),the detection rate of malignant results increased with age(χ2trend=319.091,P<0.001).The detection rates of abnormal and malignant results of female breast in different years showed an upward trend (χ2trend=106.183,P<0.001;χ2trend=12.181,P<0.001).There were 1 002 abnormal results and 5 malignant results in the physical examination group.The detection rates of abnormal results and malignant results in the physical examination group were all significantly lower than those in the non-physical examination group (χ2=1 268.803,P<0.001,χ2=102.009,P<0.001). Conclusion The screening status of female breast diseases in this region is not optimistic and needs to be further strengthened.
关键词
乳腺 /
彩超 /
筛查 /
早诊早治
Key words
Breast /
Color Doppler ultrasound /
Screening /
Early diagnosis and treatment
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
[1] Bray F,Ferlay J,Soerjomataram L,et al.Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2018,68(6) :394-424.
[2] 孙可欣,郑荣寿,顾秀瑛,等,2000—2014年中国肿瘤登记地区女性乳腺癌发病趋势及年龄变化情况分析[J].中华预防医学杂志,2018,52(6):567-572.
[3] CHEN W,ZHENG R,BAADE PD,et al.Cancer statistics in China,2015[J].CA Cancer J Clin,2016,66(2):115-132.
[4] Ohuchi N,Ishida T,Kawai M,et al.Randomized controlled trial on effectiveness of ultrasonography screening for breast cancer in women aged 40-49(J-START):research design[J].Jpn J Clin Oncol,2011,42(2):275-277.
[5] YOON JH,KIM MJ,LEE HS,et al.Validation of the fifth edition BI-RADS ultrasound lexicon with comparison of fourth and fifth edition diagnostic performance using video clips [J].Ultrasonography.2016,35(4):318-26.
[6] Mercado CL.BI-RADS Update[J].Radiol Clin North Am,2014,52(3):481-487.
[7] 程光英.合肥市2011—2012年部分地区妇女“两癌”筛查资料分析[J].安徽预防医学杂志,2013,19(5):396-397.
[8] Chen W,Zheng R,Baade PD,et al.Cancer statistics in China,2015[J].CA Cancer J Clin,2016,66(2):115-132.
[9] 路晓庆,王伏生,杨芮,等.抑郁与焦虑与乳腺癌发病关系的调查研究[J].中国药物与临床,2019,19(1):14-15.
[10] 张雪莹,赵学芳.苏州市女性乳腺癌认知和筛查行为调查结果分析[J].安徽预防医学杂志,2018,24(2):134-137.
[11] 中华预防医学会.中国女性乳腺癌筛查标准(T/CPMA 014-2020)[J].中华肿瘤防治杂志,2021,28(1):9-18.